Cargando…
Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells
BACKGROUND: Cross-talk between deregulated signaling pathways in cancer cells causes uncontrolled growth and proliferation. These cancers cells become more aggressive and quickly develop resistance to therapy. Therefore targeting of these deregulated pathways simultaneously can result in efficient c...
Autores principales: | Ahmed, Maqbool, Hussain, Azhar R, Siraj, Abdul K., Uddin, Shahab, Al-Sanea, Nasser, Al-Dayel, Fouad, Al-Assiri, Mohammed, Beg, Shaham, Al-Kuraya, Khawla S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861127/ https://www.ncbi.nlm.nih.gov/pubmed/26159723 http://dx.doi.org/10.1186/s12943-015-0406-1 |
Ejemplares similares
-
A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma
por: Siraj, Abdul K, et al.
Publicado: (2014) -
FoxM1 is an independent poor prognostic marker and therapeutic target for advanced Middle Eastern breast cancer
por: Siraj, Abdul Khalid, et al.
Publicado: (2018) -
ALK alteration is a frequent event in aggressive breast cancers
por: Siraj, Abdul K., et al.
Publicado: (2015) -
Phosphorylated IκBα Predicts Poor Prognosis in Activated B-Cell Lymphoma and Its Inhibition with Thymoquinone Induces Apoptosis via ROS Release
por: Hussain, Azhar R., et al.
Publicado: (2013) -
FoxM1 and β-catenin predicts aggressiveness in Middle Eastern ovarian cancer and their co-targeting impairs the growth of ovarian cancer cells
por: Pratheeshkumar, Poyil, et al.
Publicado: (2017)